EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial antioxidants abate SARS-COV-2 pathology in mice

Joseph W Guarnieri, Timothy Lie, Yentli E Soto Albrecht, Peter Hewin, Kellie A Jurado, Gabrielle A Widjaja, Yi Zhu, Meagan J McManus, Todd J Kilbaugh, Kelsey Keith, Prasanth Potluri, Deanne Taylor und 3 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2321972121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Joseph W Guarnieri und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: COVID-19, Antioxidants, Mitochondria, SARS-CoV-2. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute on Aging (NIA), NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection inhibits mitochondrial oxidative phosphorylation (OXPHOS) and elevates mitochondrial reactive oxygen species (ROS, mROS) which activates hypoxia-inducible factor-1alpha (HIF-1α), shifting metabolism toward glycolysis to drive viral biogenesis but also causing the release of mitochondrial DNA (mtDNA) and activation of innate immunity. To determine whether mitochondrially targeted antioxidants could mitigate these viral effects, we challenged mice expressing human angiotensin-converting enzyme 2 (ACE2) with SARS-CoV-2 and intervened using transgenic and pharmacological mitochondrially targeted catalytic antioxidants. Transgenic expression of mitochondrially targeted catalase (mCAT) or systemic treatment with EUK8 decreased weight loss, clinical severity, and circulating levels of mtDNA; as well as reduced lung levels of HIF-1α, viral proteins, and inflammatory cytokines. RNA-sequencing of infected lungs revealed that mCAT and Eukarion 8 (EUK8) up-regulated OXPHOS gene expression and down-regulated HIF-1α and its target genes as well as innate immune gene expression. These data demonstrate that SARS-CoV-2 pathology can be mitigated by catalytically reducing mROS, potentially providing a unique host-directed pharmacological therapy for COVID-19 which is not subject to viral mutational resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AntioxidantsMitochondriaSARS-CoV-2Oxidative PhosphorylationMice, TransgenicAnimalsMiceHumansAngiotensin-Converting Enzyme 2LungReactive Oxygen SpeciesHypoxia-Inducible Factor 1, alpha SubunitDNA, MitochondrialCatalaseCOVID-19 Drug TreatmentDisease Models, AnimalImmunity, Innate

Stichwörter der Autor:innen

EUK8SARS-CoV-2antioxidant therapymCATmitochondria

Substanzen

AntioxidantsAngiotensin-Converting Enzyme 2Reactive Oxygen SpeciesHypoxia-Inducible Factor 1, alpha SubunitDNA, MitochondrialCatalaseACE2 protein, human

Autor:innen und Institutionen

  • The Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
  • University of Pennsylvania, Philadelphia, PA 19104.
  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA 19104.
  • Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
  • Division of Human Genetics, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

ORCID-Profile: Douglas C Wallace

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute on Aging (NIA)
  • NCI NIH HHS
  • Bill and Melinda Gates Foundation (GF)
  • HHS | NIH | National Cancer Institute (NCI)
  • NINDS NIH HHS
  • NIA NIH HHS
  • DOD | Defense Health Agency (DHA)

Zitieren

APA

Guarnieri, J. W., Lie, T., Albrecht, Y. E. S., Hewin, P., Jurado, K. A., Widjaja, G. A., Zhu, Y., McManus, M. J., Kilbaugh, T. J., Keith, K., Potluri, P., Taylor, D., Angelin, A., Murdock, D. G., & Wallace, D. C. (2024). Mitochondrial antioxidants abate SARS-COV-2 pathology in mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2321972121

Vancouver

Guarnieri JW, Lie T, Albrecht YES, Hewin P, Jurado KA, Widjaja GA, et al. Mitochondrial antioxidants abate SARS-COV-2 pathology in mice. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2321972121

BibTeX
@article{Guarnieri2024,
  author = {Guarnieri, Joseph W and Lie, Timothy and Albrecht, Yentli E Soto and Hewin, Peter and Jurado, Kellie A and Widjaja, Gabrielle A and Zhu, Yi and McManus, Meagan J and Kilbaugh, Todd J and Keith, Kelsey and Potluri, Prasanth and Taylor, Deanne and Angelin, Alessia and Murdock, Deborah G and Wallace, Douglas C},
  title = {Mitochondrial antioxidants abate SARS-COV-2 pathology in mice},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2321972121}
}
Kostenlos starten →